This post-test assesses key insights from the 2013 Perspectives in Rheumatic Diseases Conference, focusing on advancements in rheumatoid arthritis management, including diagnostic criteria, treatment strategies, and comparative studies of biologic agents.
A. Anti-tumor necrosis factor agents
B. Biologics
C. Interleukins
D. JAK inhibitors
Rate this question:
A. Interleukin-12/23 inhibitors
B. Methotrexate
C. Systemic corticosteroids
D. Vitamin D analogs
Rate this question:
60%
70%
80%
90%
Rate this question:
2
4
6
8
Rate this question:
A. Clinical Disease Activity Index (CDAI)
B. Disease Activity Score
C. Routine Assessment of Patient Index Data (RAPID)-3
D. Simplified Disease Activity Index (SDAI)
Rate this question:
A. Elderly patients
B. Patients with comorbid conditions
C. Pediatric patients
D. Psoriasis
Rate this question:
A. The ADACTA study
B. The AMPLE study
C. The MDA study
D. The TICORA trial
Rate this question:
Quiz Review Timeline (Updated): Mar 15, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
Wait!
Here's an interesting quiz for you.